AV2.5T-SP183-fCFTRdeltaR (Spirovant Sciences/University of Iowa)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAV2.5T-SP183-fCFTRdeltaR (Spirovant Sciences/University of Iowa)
Drug Alias Nameferret cystic fibrosis transmembrane conductance regulator delta R gene therapy (Spirovant Sciences/University of Iowa)recombinant adeno-associated virus-based gene therapy (Spirovant Sciences/University of Iowa)fCFTRdeltaR gene therapy (Spirovant Sciences/University of Iowa)
ClassificationBiologics
Mechanisms of ActionCystic fibrosis transmembrane conductance regulator stimulants
TargetsCystic fibrosis transmembrane conductance regulator
Therapy Area/IndicationsCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesEU
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Iowa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe University Of IowaSpirovant Sciences Inc
Active IndicationsN/A
Inactive IndicationsCystic Fibrosis

Other Information

ATC CodeN/A
Related LinksN/A